The Role of Glucocorticoid Receptors in Podocytes and Nephrotic Syndrome

Overview

Journal Nucl Receptor Res

Date 2018 Nov 13

PMID 30417008

Citations 7

Authors

Xuan Zhao

Daw-Yang Hwang

Hung-Ying Kao

Affiliations

Soon will be listed here.

Abstract

Glucocorticoid receptor (GC), a founding member of the nuclear hormone receptor superfamily, is a glucocorticoid-activated transcription factor that regulates gene expression and controls the development and homeostasis of human podocytes. Synthetic glucocorticoids are the standard treatment regimens for proteinuria (protein in the urine) and nephrotic syndrome (NS) caused by kidney diseases. These include minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), membranous nephropathy (MN) and immunoglobulin A nephropathy (IgAN) or subsequent complications due to diabetes mellitus or HIV infection. However, unwanted side effects and steroid-resistance remain major issues for their long-term use. Furthermore, the mechanism by which glucocorticoids elicit their renoprotective activity in podocyte and glomeruli is poorly understood. Podocytes are highly differentiated epithelial cells that contribute to the integrity of kidney glomerular filtration barrier. Injury or loss of podocytes leads to proteinuria and nephrotic syndrome. Recent studies in multiple experimental models have begun to explore the mechanism of GC action in podocytes. This review will discuss progress in our understanding of the role of glucocorticoid receptor and glucocorticoids in podocyte physiology and their renoprotective activity in nephrotic syndrome.

Citing Articles

Inhibition of the glucocorticoid receptor attenuates proteinuric kidney diseases in multiple species.

Stamellou E, Agrawal S, Siegerist F, Buse M, Kuppe C, Lange T Nephrol Dial Transplant. 2023; 39(7):1181-1193.

PMID: 38037533 PMC: 11210988. DOI: 10.1093/ndt/gfad254.

Targeted nanotherapy for kidney diseases: a comprehensive review.

Sabiu G, Kasinath V, Jung S, Li X, Tsokos G, Abdi R Nephrol Dial Transplant. 2022; 38(6):1385-1396.

PMID: 35945647 PMC: 10229287. DOI: 10.1093/ndt/gfac233.

CXCL16/ERK1/2 pathway regulates human podocytes growth, migration, apoptosis and epithelial mesenchymal transition.

Chen Y, Wang Z, Li Q, Tian M, Zhu Y, Yu L Mol Med Rep. 2022; 25(6).

PMID: 35514316 PMC: 9133949. DOI: 10.3892/mmr.2022.12728.

How immunosuppressive drugs may directly target podocytes in glomerular diseases.

Salvadori M, Tsalouchos A Pediatr Nephrol. 2021; 37(7):1431-1441.

PMID: 34244853 DOI: 10.1007/s00467-021-05196-4.

Nuclear receptors in podocyte biology and glomerular disease.

Agrawal S, He J, Tharaux P Nat Rev Nephrol. 2020; 17(3):185-204.

PMID: 32943753 DOI: 10.1038/s41581-020-00339-6.

References

McCarthy E, Sharma M, Savin V . Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis. Clin J Am Soc Nephrol. 2010; 5(11):2115-21. DOI: 10.2215/CJN.03800609. View

Ransom R, Lam N, Hallett M, Atkinson S, Smoyer W . Glucocorticoids protect and enhance recovery of cultured murine podocytes via actin filament stabilization. Kidney Int. 2005; 68(6):2473-83. DOI: 10.1111/j.1523-1755.2005.00723.x. View

Morigi M, Buelli S, Angioletti S, Zanchi C, Longaretti L, Zoja C . In response to protein load podocytes reorganize cytoskeleton and modulate endothelin-1 gene: implication for permselective dysfunction of chronic nephropathies. Am J Pathol. 2005; 166(5):1309-20. PMC: 1606387. DOI: 10.1016/S0002-9440(10)62350-4. View

Brown E, Schlondorff J, Becker D, Tsukaguchi H, Tonna S, Uscinski A . Mutations in the formin gene INF2 cause focal segmental glomerulosclerosis. Nat Genet. 2009; 42(1):72-6. PMC: 2980844. DOI: 10.1038/ng.505. View

Carlotti A, Franco P, Elias L, Facincani I, Costa E, Foss N . Glucocorticoid receptors, in vitro steroid sensitivity, and cytokine secretion in idiopathic nephrotic syndrome. Kidney Int. 2004; 65(2):403-8. DOI: 10.1111/j.1523-1755.2004.00392.x. View

Huang Y, Border W, Yu L, Zhang J, Lawrence D, Noble N . A PAI-1 mutant, PAI-1R, slows progression of diabetic nephropathy. J Am Soc Nephrol. 2008; 19(2):329-38. PMC: 2396741. DOI: 10.1681/ASN.2007040510. View

Lennon R, Hosawi S . Glomerular cell crosstalk. Curr Opin Nephrol Hypertens. 2016; 25(3):187-93. PMC: 4825110. DOI: 10.1097/MNH.0000000000000221. View

Zhu X, Wu S, Dahut W, Parikh C . Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: systematic review and meta-analysis. Am J Kidney Dis. 2007; 49(2):186-93. DOI: 10.1053/j.ajkd.2006.11.039. View

Gee H, Saisawat P, Ashraf S, Hurd T, Vega-Warner V, Fang H . ARHGDIA mutations cause nephrotic syndrome via defective RHO GTPase signaling. J Clin Invest. 2013; 123(8):3243-53. PMC: 3726174. DOI: 10.1172/JCI69134. View

10.

Najafi C, Korbet S, Lewis E, Schwartz M, Reichlin M, Evans J . Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis. Kidney Int. 2001; 59(6):2156-63. DOI: 10.1046/j.1523-1755.2001.00730.x. View

11.

Herold M, McPherson K, Reichardt H . Glucocorticoids in T cell apoptosis and function. Cell Mol Life Sci. 2005; 63(1):60-72. PMC: 2792342. DOI: 10.1007/s00018-005-5390-y. View

12.

Hull R, Goldsmith D . Identifying and managing nephrotic syndrome in adults. Practitioner. 2008; 252(1703):30, 32-4, 37. View

13.

Zagury A, de Oliveira A, Montalvao J, Novaes R, Sa V, Moraes C . Steroid-resistant idiopathic nephrotic syndrome in children: long-term follow-up and risk factors for end-stage renal disease. J Bras Nefrol. 2013; 35(3):191-9. DOI: 10.5935/0101-2800.20130031. View

14.

Boute N, Gribouval O, Roselli S, Benessy F, Lee H, Fuchshuber A . NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet. 2000; 24(4):349-54. DOI: 10.1038/74166. View

15.

Bhimma R, Adhikari M, Asharam K, Connolly C . Management of steroid-resistant focal segmental glomerulosclerosis in children using tacrolimus. Am J Nephrol. 2006; 26(6):544-51. DOI: 10.1159/000097864. View

16.

Kuppe C, van Roeyen C, Leuchtle K, Kabgani N, Vogt M, van Zandvoort M . Investigations of Glucocorticoid Action in GN. J Am Soc Nephrol. 2016; 28(5):1408-1420. PMC: 5407712. DOI: 10.1681/ASN.2016010060. View

17.

Lieberman K, Tejani A . A randomized double-blind placebo-controlled trial of cyclosporine in steroid-resistant idiopathic focal segmental glomerulosclerosis in children. J Am Soc Nephrol. 1996; 7(1):56-63. DOI: 10.1681/ASN.V7156. View

18.

Wada T, Pippin J, Marshall C, Griffin S, Shankland S . Dexamethasone prevents podocyte apoptosis induced by puromycin aminonucleoside: role of p53 and Bcl-2-related family proteins. J Am Soc Nephrol. 2005; 16(9):2615-25. DOI: 10.1681/ASN.2005020142. View

19.

Schwarz K, Simons M, Reiser J, Saleem M, Faul C, Kriz W . Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin. J Clin Invest. 2001; 108(11):1621-9. PMC: 200981. DOI: 10.1172/JCI12849. View

20.

Yang Y, Zhao F, Tu X, Yu Z . Mutations in WT1 in boys with sporadic isolated steroid-resistant nephrotic syndrome. Genet Mol Res. 2016; 15(1):15017559. DOI: 10.4238/gmr.15017559. View